Expanding the frontiers of schistosomiasis treatment: The promise of nanoparticle-based therapies.

Schistosomiasis is one of the most overlooked parasitic diseases worldwide. The new roadmap for neglected tropical diseases (2021-2030), adopted by the World Health Assembly, sets global goals for combating these diseases. eliminating schistosomiasis. Current treatment options for schistosomiasis, such as Praziquantel, are limited. Nanoparticle-based treatments and vaccines have shown promise in overcoming the limitations of Praziquantel therapy by offering targeted and sustained drug delivery. We advocate prioritizing and enhancing funding and collaboration for nanoparticle research targeting schistosomiasis. By investing in these innovative solutions in regions most impacted by schistosomiasis, we have the potential to alleviate the treatment burden and enhance patient adherence. This review paper explores anotechnological solutions, current trends, and long-term outcomes.